Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Fernando Notario-Pérez, Roberto Ruiz-Caro & María-Dolores Veiga-Ochoa. (2017) Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes. Drug Design, Development and Therapy 11, pages 1767-1787.
Read now
Read now
Yufei Chen, Yannick Leandre Traore, Amanda Li, Keith R Fowke & Emmanuel A Ho. (2014) Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine. Drug Design, Development and Therapy 8, pages 1801-1815.
Read now
Read now
Ian McGowan. (2014) The development of rectal microbicides for HIV prevention. Expert Opinion on Drug Delivery 11:1, pages 69-82.
Read now
Read now
Articles from other publishers (19)
Partha Biswas, Mohammad Mehedi Hasan, Dipta Dey, Ana Carla dos Santos Costa, Shakil Ahmed Polash, Shabana Bibi, Nadim Ferdous, Md. Abu Kaium, MD. Hasanur Rahman, Fardin Kamal Jeet, Stavros Papadakos, Khairul Islam & Md. Sahab Uddin. (2021) Candidate antiviral drugs for COVID-19 and their environmental implications: a comprehensive analysis. Environmental Science and Pollution Research 28:42, pages 59570-59593.
Crossref
Crossref
Samrajya Lakshmi Yeruva, Prashant Kumar, Seetharam Deepa & Anand K Kondapi. (2021) Lactoferrin nanoparticles coencapsulated with curcumin and tenofovir improve vaginal defense against HIV-1 infection. Nanomedicine 16:7, pages 569-586.
Crossref
Crossref
Stella E. Aniagyei, Lee B. Sims, Danial A. Malik, Kevin M. Tyo, Keegan C. Curry, Woihwan Kim, Daniel A. Hodge, Jinghua Duan & Jill M. Steinbach-Rankins. (2017) Evaluation of poly(lactic-co-glycolic acid) and poly( dl -lactide-co-ε-caprolactone) electrospun fibers for the treatment of HSV-2 infection. Materials Science and Engineering: C 72, pages 238-251.
Crossref
Crossref
Thalía Garcia-Tellez, Nicolas Huot, Mickaël J. Ploquin, Philippe Rascle, Beatrice Jacquelin & Michaela Müller-Trutwin. (2016) Non-human primates in HIV research: Achievements, limits and alternatives. Infection, Genetics and Evolution 46, pages 324-332.
Crossref
Crossref
Tiffany N. Grooms, Hung R. Vuong, Kevin M. Tyo, Danial A. Malik, Lee B. Sims, Carli P. Whittington, Kenneth E. Palmer, Nobuyuki Matoba & Jill M. Steinbach-Rankins. (2016) Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection. Antimicrobial Agents and Chemotherapy 60:11, pages 6518-6531.
Crossref
Crossref
Kieran Seay, Nazanin Khajoueinejad, Jian Hua Zheng, Patrick Kiser, Christina Ochsenbauer, John C. Kappes, Betsy Herold & Harris Goldstein. (2015) The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment. Journal of Virology 89:18, pages 9559-9570.
Crossref
Crossref
Sophia G. Antimisiaris & Spyridon Mourtas. (2015) Recent advances on anti-HIV vaginal delivery systems development. Advanced Drug Delivery Reviews 92, pages 123-145.
Crossref
Crossref
Irina A. Zalenskaya, Theresa Joseph, Jasmin Bavarva, Nazita Yousefieh, Suzanne S. Jackson, Titilayo Fashemi, Hidemi S. Yamamoto, Robert Settlage, Raina N. Fichorova & Gustavo F. Doncel. (2015) Gene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates. PLOS ONE 10:6, pages e0128557.
Crossref
Crossref
Jill M. Steinbach. (2014) Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs. Cellular and Molecular Life Sciences 72:3, pages 469-503.
Crossref
Crossref
Javier Sánchez-Rodríguez, Enrique Vacas-Córdoba, Rafael Gómez, F. Javier De La Mata & Ma Ángeles Muñoz-Fernández. (2015) Nanotech-derived topical microbicides for HIV prevention: The road to clinical development. Antiviral Research 113, pages 33-48.
Crossref
Crossref
Mackenzie L. Cottrell & Angela D.M. Kashuba. (2014) Topical microbicides and HIV prevention in the female genital tract. The Journal of Clinical Pharmacology 54:6, pages 603-615.
Crossref
Crossref
Humberto González-Díaz, Diana María Herrera-Ibatá, Aliuska Duardo-Sánchez, Cristian R. Munteanu, Ricardo Alfredo Orbegozo-Medina & Alejandro Pazos. (2014) ANN Multiscale Model of Anti-HIV Drugs Activity vs AIDS Prevalence in the US at County Level Based on Information Indices of Molecular Graphs and Social Networks. Journal of Chemical Information and Modeling 54:3, pages 744-755.
Crossref
Crossref
Onkar Singh, Tarun Garg, Goutam Rath & Amit K. Goyal. (2014) Microbicides for the Treatment of Sexually Transmitted HIV Infections. Journal of Pharmaceutics 2014, pages 1-18.
Crossref
Crossref
Enrique Vacas Córdoba, Eduardo Arnáiz, Francisco J. De La Mata, Rafael Gómez, Manuel Leal, Marjorie Pion & Ma Ángeles Muñoz-Fernández. (2013) Synergistic activity of carbosilane dendrimers in combination with maraviroc against HIV in vitro. AIDS 27:13, pages 2053-2058.
Crossref
Crossref
Zheng Shen, John V. Fahey, Jack E. Bodwell, Marta Rodriguez-Garcia, Richard M. Rossoll, Sarah G. Crist, Mickey V. Patel & Charles R. Wira. (2013) Estradiol Regulation of Nucleotidases in Female Reproductive Tract Epithelial Cells and Fibroblasts. PLoS ONE 8:7, pages e69854.
Crossref
Crossref
V. Savasi, L. Mandia, A. Laoreti & I. Cetin. (2012) Reproductive assistance in HIV serodiscordant couples. Human Reproduction Update 19:2, pages 136-150.
Crossref
Crossref
Catherine A. Hankins & Mark R. Dybul. (2013) The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission. Current Opinion in HIV and AIDS 8:1, pages 50-58.
Crossref
Crossref
Lut Van Damme & Michael Szpir. (2012) Current status of topical antiretroviral chemoprophylaxis. Current Opinion in HIV and AIDS 7:6, pages 520-525.
Crossref
Crossref
Christophe Vanpouille, Anush Arakelyan & Leonid Margolis. (2012) Microbicides: still a long road to success. Trends in Microbiology 20:8, pages 369-375.
Crossref
Crossref